There are 165 ASX-listed companies in the Health Care sector.
Syntara’s SNT-4728 produced a statistically significant difference in clinician-assessed motor signs 12 weeks after treatment ended. The exploratory result adds to earlier evidence of reduced brain inflammation.
07 Oct 2026, 10:18 am · 2 min read
dorsaVi has secured A$3 million to expand its human movement data capabilities for humanoid robotics and progress its RRAM validation chip program.
06 Oct 2026, 10:14 am · 2 min read
Artrya has secured its largest US deployment to date through a five-year agreement with Huntsville Hospital Health System. The contract has a US$500,000 minimum value, with additional fee-per-scan revenue possible.
02 Oct 2026, 10:18 am · 2 min read
Vectus Biosystems has secured an FDA pre-IND meeting for lead fibrosis candidate VB0004. Written guidance expected by mid-November 2026 will inform the program’s next steps.
30 Sept 2026, 10:14 am · 2 min read
Neuren Pharmaceuticals expects US patent protection for trofinetide to extend by almost five years to March 2041 following allowance of a weight-banded dosing patent application.
29 Sept 2026, 10:10 am · 2 min read
Argent BioPharma has licensed commercial rights to NLC’s Tollovir, Tollovid and NutraVir antiviral applications. The deal includes US$300,000 in scheduled base fees, tiered royalties and sales-linked consideration.
29 Sept 2026, 10:05 am · 2 min read
Lumos Diagnostics has increased FebriDx’s US footprint to 215 live sites and 405 sites under evaluation. Two top-100 urgent care groups will roll out the test across more than 40 combined locations.
15 Sept 2026, 10:32 am · 2 min read
Telix Pharmaceuticals has received US FDA approval for Pixclara, the first approved FET-PET imaging drug for glioma. The indication covers adults and children aged one month or older.
14 Sept 2026, 11:43 am · 2 min read
Dimerix will initially draw A$17 million from a A$34 million facility to fund its kidney-disease clinical programs. The debt carries 10% annual interest and milestone participation rights.
04 Sept 2026, 09:55 am · 2 min read
Immuron has secured exclusive US distribution rights for Calmino’s PROIBS digestive-health medical device. Launch timing and financial terms were not disclosed.
04 Sept 2026, 09:42 am · 2 min read
The FDA has accepted and closed Imricor’s manufacturing module covering seven products. Final approval still requires completion of all reviews and a site inspection.
03 Sept 2026, 10:34 am · 2 min read
EMVision has completed remote hospital site visits and received a $337,425 progress payment. Its study will assess the emu brain scanner in regional stroke care.
03 Sept 2026, 09:28 am · 2 min read
AdAlta partner SHcell can provide BZDS1901 to eligible advanced mesothelioma patients in Hainan. The scheme will generate real-world data for AdAlta’s EW-001 program.
02 Sept 2026, 10:02 am · 2 min read
Optiscan has begun recruiting patients for a Mayo Clinic head and neck cancer study. Data will support planned US FDA submissions for InVue and InForm later in 2026.
01 Sept 2026, 10:06 am · 2 min read
Mesoblast’s Ryoncil launch lifted annual revenue to US$120.3 million and helped narrow its net loss. The company also completed treatment in a 350-patient Phase 3 back-pain trial.
27 Aug 2026, 10:02 am · 2 min read
30-day announcements
| Rank | ASX code | Company | 30-day announcements |
|---|---|---|---|
| 1 | HLS | HEALIUS LIMITED | 25 |
| 2 | EBO | EBOS GROUP LIMITED | 17 |
| 3 | AYA | ARTRYA LIMITED | 16 |
| 4 | NAN | NANOSONICS LIMITED | 16 |
| 5 | PAR | PARADIGM BIOPHARMACEUTICALS LIMITED.. | 16 |
Bold Investors provides factual news coverage of ASX company announcements. Nothing on this page is financial advice. Articles are grounded in the company's own announcements.
![[ASX: DVL] DORSAVI LTD a humanoid robot beside a person wearing compact movement sensors in a biomechanics testing space, framed widely to](/media/hero/164b27bc-b923-4d00-ad47-e7f689f9663f/1791264301015-adc3f600-1536w.webp)
![[ASX: AYA] ARTRYA LIMITED a radiologist and cardiologist reviewing coronary CT images and a three-dimensional coronary artery model on medical workstations inside](/media/hero/81ef03e1-02fb-492f-b4d5-a8cb1b56a72d/1790900297914-3627b902-1536w.webp)
![[ASX: VBS] VECTUS BIOSYSTEMS LIMITED a biotechnology researcher in a laboratory examining lung-tissue samples beside analytical instruments, framed with the scientist in](/media/hero/e3d1b8a7-7778-416b-aec3-c04f105c749e/1790749714634-0e371c85-1536w.webp)
![[ASX: NEU] NEUREN PHARMACEUTICALS LIMITED a close-up pharmaceutical laboratory scene showing measured oral liquid medication beside precision dispensing equipment, with researchers working](/media/hero/49851683-7dc0-4f64-abd0-3260d8819b38/1790758524207-5f0dadea-1536w.webp)
![[ASX: RGT] ARGENT BIOPHARMA LIMITED a pharmaceutical research setting showing a scientist examining botanical compounds in glass laboratory vessels, with microscopes and](/media/hero/d2fc35c3-cabb-41d7-af5d-632cb6c70023/1790720821104-d84d7206-1536w.webp)
![[ASX: LDX] LUMOS DIAGNOSTICS HOLDINGS LIMITED a close clinical scene showing a healthcare worker handling a rapid diagnostic cassette, with multiple softly](/media/hero/d1889806-5647-4647-8efd-77bd9c890c55/1789439889838-27b96531-1536w.webp)
![[ASX: TLX] TELIX PHARMACEUTICALS LIMITED a hospital nuclear-medicine suite with a patient entering a PET scanner, while a neurologist reviews a glowing](/media/hero/f9eaead5-f4fe-4806-bff8-7494d517e10a/1789359018715-5f90e7d7-1536w.webp)
